Literature DB >> 3301843

Insulin as a growth factor in rat hepatoma cells. Stimulation of proto-oncogene expression.

R Taub, A Roy, R Dieter, J Koontz.   

Abstract

In a subline of Reuber H35 rat hepatoma cells that becomes quiescent under serum-deprived conditions, insulin acts as a growth factor. When added to serum-deprived H35 cells, physiologic concentrations of insulin stimulate DNA synthesis, demonstrating that insulin alone is capable of inducing a transition from G0/G1 into S phase. This response, which is induced by nanomolar concentrations of insulin, is mediated directly through the insulin receptor. Here we show that coincident with this growth response, insulin or serum induces dramatic increases in the steady-state levels of c-fos and c-myc mRNAs in serum-deprived H35 cells in a time course similar to that observed in the regenerating liver. Other growth factors, including epidermal growth factor, appear not to affect these cells either in terms of DNA synthesis or c-myc mRNA induction. The phorbol ester phorbol 12-myristate 13-acetate (PMA) also induces c-myc and c-fos mRNAs without inducing DNA synthesis. However, the mechanism of this induction appears to be different from the insulin-induced induction since pretreatment of cells with PMA blocks only the PMA-mediated, not the insulin-mediated, induction of c-myc and c-fos.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301843

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA.

Authors:  J Ostrowski; Y Kawata; D S Schullery; O N Denisenko; Y Higaki; C K Abrass; K Bomsztyk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  Direct stimulation of immediate-early genes by intranuclear insulin in trypsin-treated H35 hepatoma cells.

Authors:  Y J Lin; S Harada; E G Loten; R M Smith; L Jarett
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 4.  Regulation of gene expression by insulin.

Authors:  R M O'Brien; D K Granner
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

5.  The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes.

Authors:  K L Mohn; T M Laz; J C Hsu; A E Melby; R Bravo; R Taub
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

6.  An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo.

Authors:  N Nasrin; L Ercolani; M Denaro; X F Kong; I Kang; M Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Transferrin is an autocrine growth factor secreted by Reuber H-35 cells in serum-free culture.

Authors:  L E Shapiro; N Wagner
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

9.  PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth.

Authors:  R H Diamond; D E Cressman; T M Laz; C S Abrams; R Taub
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone.

Authors:  A Debant; E Clauser; G Ponzio; C Filloux; C Auzan; J O Contreres; B Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.